Evolution of sequential bortezomib-dexamethasone treatment followed by autologous hematopoietic stem cell transplantation in hemodialysis treatment

被引：0
|
作者：
Li Cavoli Gioacchino [1 ]
Zagarrigo Carmela [1 ]
Servillo Franca [1 ]
Coglitore Mario [1 ]
Schillaci Onofrio [1 ]
Tralongo Angelo [1 ]
Rotolo Ugo [1 ]
机构：
[1] Nephrology and Dialysis,Civic and Di Cristina Hospital
来源：
中华医学杂志（英文版） | 2013年 / 126卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R457 [血液疗法];
学科分类号：
100215 ;
摘要：
To the editor:We read with interest the article of Zheng et al~1on sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation(ASCT)in patients with multiple myeloma(MM).
引用
收藏
页码：1795 / 1795
相关论文
共 50 条
  • [1] Evolution of sequential bortezomib-dexamethasone treatment followed by autologous hematopoietic stem cell transplantation in hemodialysis treatment
    Gioacchino, Li Cavoli
    Carmela, Zagarrigo
    Franca, Servillo
    Mario, Coglitore
    Onofrio, Schillaci
    Angelo, Tralongo
    Ugo, Rotolo
    CHINESE MEDICAL JOURNAL, 2013, 126 (09) : 1795 - 1795
  • [2] Sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation in patients with multiple myeloma
    ZHENG Dong
    LI Juan
    HUANG Bei-hui
    LIU Jun-ru
    ZOU Wai-yi
    SU Chang
    中华医学杂志（英文版）, 2012, (24) : 4454 - 4459
  • [3] Sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation in patients with multiple myeloma
    Zheng Dong
    Li Juan
    Huang Bei-hui
    Liu Jun-ru
    Zou Wai-yi
    Su Chang
    CHINESE MEDICAL JOURNAL, 2012, 125 (24) : 4454 - 4459
  • [4] Sequential treatment with bortezomib plus thalidomide plus dexamethasone followed by autologous hematopoietic stem cell transplantation (HSCT); consolidation and maintenance therapy in patients with multiple myeloma
    Bachiri, A.
    Bekadja, M. A.
    Talhi, S.
    Abderrahmani, S.
    Ouldjeriouat, H.
    Bouhass, R.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S509 - S509
  • [5] Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation
    Ishii, Yoshimi
    Yamazaki, Etsuko
    Ishiyama, Yasufumi
    Yamamoto, Eri
    Hattori, Yukako
    Hagihara, Maki
    Tomita, Naoto
    Ishigatsubo, Yoshiaki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (06) : 723 - 728
  • [6] Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation
    Yoshimi Ishii
    Etsuko Yamazaki
    Yasufumi Ishiyama
    Eri Yamamoto
    Yukako Hattori
    Maki Hagihara
    Naoto Tomita
    Yoshiaki Ishigatsubo
    International Journal of Hematology, 2013, 98 : 723 - 728
  • [7] A STAGED APPROACH WITH VINCRISTINE, ADRIAMYCIN AND DEXAMETHASONE FOLLOWED BY BORTEZOMIB, THALIDOMIDE AND DEXAMETHASONE BEFORE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE TREATMENT OF NEWLY DIAGNOSED MULTIPLE MYELOMA
    Chim, C.
    Lie, A. K.
    Chan, E. Y.
    Leung, Y. Y.
    Cheung, S. C.
    Chan, S. Y.
    Liang, R.
    Kwong, Y. L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 593 - 593
  • [8] A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma
    Chim, C. S.
    Lie, A. K. W.
    Chan, E. Y. T.
    Leung, Y. Y.
    Cheung, S. C. W.
    Chan, S. Y. T.
    Liang, Raymond
    Kwong, Y. L.
    ANNALS OF HEMATOLOGY, 2010, 89 (10) : 1019 - 1027
  • [9] A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma
    C. S. Chim
    A. K. W. Lie
    E. Y. T. Chan
    Y. Y. Leung
    S. C. W. Cheung
    S. Y. T. Chan
    Raymond Liang
    Y. L. Kwong
    Annals of Hematology, 2010, 89 : 1019 - 1027
  • [10] Bortezomib/dexamethasone followed by autologous stem cell transplantation as front line treatment for light-chain deposition disease
    Tovar, Natalia
    Teresa Cibeira, Ma
    Rosinol, Laura
    Sole, Manel
    Fernandez de larrea, Carlos
    Escoda, Lourdes
    Rovira, Montserrat
    Blade, Joan
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (04) : 340 - 344
12345